Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
10/2010
10/12/2010US7812041 such as 2-Morpholin-4-yl-thiazole-4-carboxylic acid (5,6-dimethyl-1H-benzoimidazol-2-yl)-amide, used for the treatment of dementia, amyotrophic lateral sclerosis, stroke, epilepsy, multiple sclerosis, myasthenia gravis, Huntington's, Alzheimer's, Parkinson's, Meniere's and Creutzfeld-Jacob Disease
10/12/2010US7812040 Histamine-3 receptor antagonists
10/07/2010WO2010114971A1 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
10/07/2010WO2010113184A1 Kinetic resolution of (4s)-4-phenyl-3-[5(rs)-(4-fluorophenyl)-5-hydroxypentanoyl] -1,3 oxazolidin 2-one to (5s) isomer via lipase catalyzed enantioselective esterification of the (5r) isomer
10/07/2010WO2010113182A1 Intermediates in the preparation of 1,4-diphenyl azetidinone
10/07/2010WO2010112116A1 Heterocyclic compounds as autotaxin inhibitors
10/07/2010WO2010112092A1 Compounds for treatment of duchenne musculary dystrophy
10/07/2010WO2010112091A1 Compounds for treatment of duchenne muscular dystrophy
10/07/2010US20100256923 Compounds for neutron radiation detectors and systems thereof
10/07/2010US20100256385 Prostaglandin e receptor antagonists
10/07/2010US20100256367 Pharmaceutical Composition For Preventing and Treating Metabolic Bone Diseases Containing Alpha-Arylmethoxyactylate Derivatives
10/07/2010US20100256201 Cell differentiation inducer
10/07/2010US20100256165 Large conductance calcium-activated k channel opener
10/07/2010US20100256131 Carbonyl compounds
10/07/2010US20100256130 Morpholinyl and pyrrolidinyl analogs
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010CA2757722A1 Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
10/07/2010CA2757413A1 Heterocyclic compounds as autotaxin inhibitors
10/07/2010CA2756989A1 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
10/06/2010EP2234990A1 Bifeprunox derivatives
10/06/2010CN1942186B Pyrrolidine compounds
10/06/2010CN101855213A Therapeutic compounds
10/06/2010CN101855212A Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain
10/06/2010CN101851235A Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same
10/06/2010CN101851214A Method for synthesizing polyarylation substituted oxazolidine
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/06/2010CN101849953A Inflammatory cytokine release inhibitor
10/06/2010CN101323589B Preparation of novel compound and montelukast sodium
10/05/2010US7807842 Synthesis of tetracyclines and analogues thereof
10/05/2010US7807841 Spiro-containing compounds and compositions as modulators of steroid hormone nuclear receptors
10/05/2010US7807701 Dibenzylamine compounds and pharmaceutical use thereof
10/05/2010US7807700 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
10/05/2010US7807697 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile
10/05/2010US7807692 peroxisome proliferator activated receptor agonists useful in the treatment and control of hyperglycemia that is symptomatic of non-insulin dependent diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia and obesity that are often associated with type II diabetes
10/05/2010US7807669 Peroxisome proliferator-activated receptor type gamma (PPAR- gamma) modulators such as (S)-3-{3'-[(benzoylmethylamino)methyl]biphenyl-4-yl}-2-(1-methyl-3-oxo-3-phenylpropenylamino)propionic acid, suited for use in dermatology, immunology, cardiovascular diseases and/or hyperlipemia
09/2010
09/30/2010WO2010111303A2 Imaging agents for detecting neurological disorders
09/30/2010WO2010108903A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010WO2009157019A3 Process for preparing ezetimibe using novel allyl intermediates
09/30/2010US20100249428 Process for the preparation of propionic acid derivatives
09/30/2010US20100249349 Novel Polymers
09/30/2010US20100249124 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249123 Novel benzamide derivatives as modulators of the follicle stimulating hormone
09/30/2010US20100248313 Novel optically active, heteroaromatic beta-hydroxy esters and processes for their preparation from beta-keto esters and processes for the preparation of these beta-keto esters
09/30/2010CA2756137A1 Imaging agents for detecting neurological disorders
09/30/2010CA2754176A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/29/2010CN101845025A Preparation method of 3-alpha,beta-unsaturated acyl-1,3-oxazolidine-2-ketone
09/28/2010US7803954 Mandelic acid derivatives and their use as thrombin inhibitors
09/28/2010US7803950 Method for the production of diarylcycloalkyl derivatives
09/28/2010US7803797 Substituted arylcyclopentenes as therapeutic agents
09/28/2010CA2429267C Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
09/28/2010CA2383524C Thiazolyl alkynyl compounds and methods of use thereof
09/23/2010WO2010108067A1 Alpha-(n-benzenesulfonamido)cycloalkyl derivatives
09/23/2010US20100240721 desoxyepothilone A and B; Fludelone; anticarcinogenic agents; drug resistance; water solubility for formulability; industrial scale; cytotoxic or growth inhibitory effects on CAG myeloma cells lines; ability to polymerize tubulin; minimum toxicity; stabilizing microtubules
09/23/2010US20100240708 Alpha-(N-Benzenesulfonamido)Cycloalkyl Derivatives
09/23/2010US20100240659 Nitrogen-containing heterocyclic derivative having 11ss-hydroxysteroid dehydrogenase type i inhibitory activity
09/23/2010US20100240657 Chemical compounds
09/23/2010US20100239551 Compounds and compositions as channel activating protease inhibitors
09/22/2010EP1853565B1 Menthane carboxamide derivatives having cooling properties
09/21/2010US7799927 optical recording media with said organic dye as recording layer; high density Disk-Recordable (HD DVD-R)
09/21/2010US7799828 selective estrogen receptor modulators such as 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene)methyl]benzoic acid, used for the treatment of osteoporosis, obesity, breast cancer, depression, vaginal dryness, rheumatoid arthritis, vasomotor symptoms and urogenital or vulvar vaginal atrophy
09/21/2010CA2590575C 3-phenylpropionic acid derivatives and their use as ppar- gamma receptor ligands
09/21/2010CA2411111C Thiazolyl, oxazolyl and pyrazolyl-substituted heterocycles and their use as pesticides and herbicides
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/16/2010WO2010103281A1 Cyclic carbamate compounds useful in energy-curable compositions
09/16/2010WO2010062490A3 Method for making carbamates, ureas and isocyanates
09/16/2010US20100234591 Biaryl heterocyclic compounds and methods of making and using the same
09/16/2010US20100234365 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
09/16/2010US20100234364 Ccr2 inhibitors and methods of use thereof
09/16/2010DE102009012445A1 New substituted bisoxazoline ligands, useful as chiral catalyst in asymmetric organic synthesis, preferably nitroaldol reaction
09/16/2010CA2754712A1 Cyclic carbamate compounds useful in energy-curable compositions
09/15/2010EP2227453A2 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
09/15/2010EP1836150B1 Hydroxyphenol derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
09/15/2010CN101835762A 2-aminooxazole derivatives as TRPV1 antagonists useful for treating pain
09/15/2010CN101835745A Process for production of disulfonic acid compound, asymmetric mannich catalyst, process for production of beta-aminocarbonyl derivative, and novel disulfonate salt
09/15/2010CN101830894A Benzo[d]oxazole compounds and preparation method thereof
09/15/2010CN101830860A Copper ion hapten penicillenic acid mercaptan copper salt and preparation method thereof
09/15/2010CN101830855A Substituted nitrogen-containing benzoheterocycle compounds and preparation method and application thereof
09/14/2010US7795291 Glycine, N-[[3-[[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]methoxy]phenyl]methyl]-N-(methoxycarbonyl)-, used for treating atherosclerosis, dyslipidemia, diabetes, non-insulin dependent diabetes, hyperglycemia, hyperinsulinemia and obesity
09/14/2010US7795251 such as 3-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-7-hydroxy-3,4-dihydro-benzo[e][1,3]oxazin-2-one, inhibitors macrophage migration inhibitory factor isomerase activity; treatment of vision defects, ischemia, inflammatory, autoimmune, bone, nervous system, cardiovascular and gastrointestinal disorders
09/14/2010CA2584311C Synthesis of amino acid, n-carboxyanhydrides
09/10/2010WO2010101247A1 Cyclohexane derivative having npy y5 receptor antagonism
09/09/2010US20100227902 Bis-aryl sulfonamides
09/09/2010US20100227901 Compounds for the treatment of metabolic disorders
09/09/2010US20100226882 Linked diimidazole antivirals
09/08/2010EP2225216A1 Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders
09/08/2010EP2225215A1 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
09/08/2010EP2019822B1 A new process for the synthesis of 2-aminoxazole compounds
09/08/2010EP1382336B1 Use of the abc expression promotor pioglitazone for the treatment of arteriosclerosis obliterans
09/07/2010US7790903 Process for production of optically active PPAR-activating compound and intermediate of the same
09/07/2010US7790726 chemokine receptor antagonists such as 6-Chloro-3-{2-[4-(4-chloro-3-methoxy-phenyl)-4-hydroxy-piperidin-1-yl]-2-oxo-ethyl}-3H-benzooxazol-2-one, having in vivo antiinflammatory activity
09/07/2010CA2179935C Novel dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
09/02/2010US20100222580 Process For The Preparation Of Onium Alkylsulfates Having A Low Halide Content
09/02/2010US20100222326 New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
09/02/2010US20100221764 Novel nitroreductase enzymatic substrates
09/01/2010EP2224013A1 Methods for the determination of telomerase activity using click chemistry
09/01/2010EP2222654A1 2-methylthioethyl-substituted heyrrocycles as feed additives
09/01/2010EP1555261B1 Valerolactone compounds and perfume composition
09/01/2010EP1379508B1 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
09/01/2010CN101821238A Compounds which inhibit BETA-SECRETASE activity and methods of use thereof
09/01/2010CN101817799A Cyanoacrylate compound and application thereof in pesticide and medicine
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 210